Catalyst Wire Dossier Catalyst Wire Dossier

BPZE1 Intranasal Pertussis Vaccine

BPZE1 · ILiAD Biotechnologies
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BPZE1 Intranasal Pertussis Vaccine, covering 2025-11-06 to 2025-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children [Phase 2]

See pricing